Humans to be genetically-modified in Europe for the first time this year using gene-splicing therapy – The biotech company Crispr Therapeutics is hoping to cure the disease beta thalassaemia.

Europe will see its first genetically engineered patients using a groundbreaking gene-splicing therapy this year after regulators approved trials.

https://www.telegraph.co.uk/science/2018/04/15/europe-see-first-genetically-engineered-patients-using-gene/

About Robert Zinn

Robert Zinn, M.D., Ph.D. is a medical doctor, physician, and web entrepreneur, who, for over 15 years was employed by academic and research institutions and focused his clinical practices on very specialized patient populations, such as those with rare genetic diseases or rare cancers. He shares his knowledge through his website, NutritionTheory.org

View all posts by Robert Zinn →